Article Sidebar

Submitted
Apr 26, 2021
Published
Apr 26, 2021
Download
PDF
Statistic
Read Counter : 41 Download : 27

Main Article Content

Abstract

Current review was regarding Diabetes mellitus along with its causes for foot ulcer. Many studies were conducted regarding etiology of diabetes mellitus. This review highlights the prevalence of diabetes and its neuropathic complications leading to ulceration stage. Current review details the underlying mechanism foot ulcer and its reason. Diabetes mellitus is increasingly common conditions in low income countries that expose patients to increased risk of mortality and morbidity. There is a long preclinical period (up to 9 to 13 years) marked by the presence of immune markers when β-cell destruction is thought to occur. Hyperglycemia occurs when 80% to 90% of β- cells are destroyed. There is a transient remission followed by established disease with associated risks for complications and death. Type 2 diabetes is usually characterized by the presence of both insulin resistance and relative insulin deficiency. Insulin resistance is manifested by increased lipolysis and free fatty acid production, increased hepatic glucose production, and decreased skeletal muscle uptake of glucose. β-Cell dysfunction is progressive and contributes to worsening blood glucose control over time.  Identifying participants in the pre-clinical stages by screening offers participants and providers an opportunity to modify long-term risk before serious complications occur. Early detection of diabetes can be facilitated by periodic screening of the people regularly. Counselling of the community may help in lifestyle modification and its role in controlling hypertension and diabetes along with its complications and which should also be emphasized.

Keywords

Diabetes mellitus Foot ulcer Prediabetes Peripheral neuropathy

Article Details

How to Cite
Reshma UR, Lakshmi I, Prasanth Kumar S, Venkateswaramurthy N, & Sambath Kumar R. (2021). A review on causes of diabetes and foot ulcer. International Journal of Research in Pharmacology & Pharmacotherapeutics, 4(4), 435-440. https://doi.org/10.61096/ijrpp.v4.iss4.2015.435-440
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. World Health Organization: Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks.
  2. http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf. Published December 11, 2010. Accessed June 18, 2014.
  3. [2]. Oster JR, Materson BJ, Epstein M: Diabetes mellitus and hypertension. Cardiovascular Risk Factors. 1990; l: 25-46.
  4. [3]. Danaei G, Finucane MM, Lu Y. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011; 378: 31–40.
  5. [4]. Chow CK, Raju PK, Raju R, Reddy KS, Cardona M, Celermajer DS, Neal BC. The prevalence and management of diabetes in rural India. Diabetes Care. 2006; 29: 1717–1718.
  6. [5]. Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001; 44(9): 1094-101.
  7. [6]. Mohan V, Deepa M, Farooq S, Datta M. Prevalence, Awareness and Control of Hypertension in Chennai - The Chennai Urban Rural Epidemiology Study (CURES – 52). Journal of the Association of Physicians of India.2007; 55: 326-32.
  8. [7]. Joshi SR, Banshi S, Muruga V, et al., Prevalence of Diagnosed and Undiagnosed Diabetes and Hypertension in India—Results from the Screening India’s Twin Epidemic (SITE) Study. Diabetes Technology and Therapeutics. 2012; 14(1): 8-15.
  9. [8]. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047-53.
  10. [9]. Kutty VR, Soman CR, Joseph A, Pisharody R, VijayakumarK. Type 2 diabetes in southern Kerala. Variation in prevalence among geographic divisions within a region. The National Medical Journal of India. 2000; 13: 287-92.
  11. [10]. Ramachandran A, Snehalatha C, Kapur A, Vijay V. Diabetes Epidemiology Study Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001; 44: 1094-101.
  12. [11]. Reddy KS, Shah B, Varghese C, Ramadoss A. Chronic diseases 3. Lancet. 2005; 366: 1746-51.
  13. [12]. International Diabetes Federation. Diabetes Atlas. 4th ed. Brussels: International Diabetes Federation, 2009: 213-18.
  14. [13]. World Health Organization. Screening for Type 2 Diabetes: Report of a World Health Organisation and International Diabetes Federation Meeting [Internet], 2003. Available from www.who.int/diabetes/publications/en/screening_mnc03. pdf. Accessed 15 April 2014.
  15. [14]. Chow CK, Raju PK, Raju R, Reddy KS, Cardona M, Celermajer DS, Neal BC. The prevalence and management of diabetes in rural India. Diabetes Care. 2006; 29: 1717–1718.
  16. [15]. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. New England Journal of Medicine. 2008; 358: 580 –591.
  17. [16]. Control Group, Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, Neal BC, Ninomiya T, Patel AA, Paul SK, Travert F, Woodward M. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009; 52: 2288 –2298.
  18. [17]. Castelli WP: Epidemiology of coronary heart disease .The Framinghan Study. American Journal of Medicine. 1984; 76: 4–12.
  19. [18]. National diabetes statistics report. www.cdc.gov/diabeteS/pubs/statsrepor. Published June 13, 2014. Accessed June 16, 2014.
  20. [19]. All About Pre-Diabetes.
  21. http://professional.diabetes.org/admin/UserFiles/file/Reducing%20Cardiometabolic%20Risk_%20Patient%20Education%20Toolkit/English/ADA%20CMR%20Toolkit_3Pre.pdf. Published December 22, 2010. Accessed April 23, 2014.
  22. [20]. Guideline principles for diabetes care. http://ndep.nih.gov/media/guidprin_hc_eng.pdf. Published April 16, 2009. Accessed April 23, 2014.
  23. [21]. Richard E Pratley, Glenn Matfin. Pre-diabetes: Clinical Relevance and Therapeutic Approach. The British Journal of Diabetes and Vascular Disease. 2007; 7(3): 120-129.
  24. [22]. Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA. Effects of diet and sodium intake on blood pressure. Annals Of Internal Medicine. 2001; 135: 1019-28.
  25. [23]. DIABETES. http://collab.nlm.nih.gov/webcastsandvideos/drew/diabetes.pdf. Published May 2, 2010. Accessed June 18, 2014.
  26. [24]. Buchanan TA. Diabetes. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes. 2002; 51(9): 2796-803.
  27. [25]. Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA. Effects of diet and sodium intake on blood pressure. Annals Of Internal Medicine. 2001; 135: 1019-28.
  28. [26]. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 1990;13:513-521.
  29. [27]. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150-154.
  30. [28]. Reiber GE, Vileikyte L, Boyko EJ. et al. Causal pathways for incident lower extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22:157-162.
  31. [29]. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study. Diabetes Care. 1994;17:557-560.
  32. [30]. Sanders LJ. Diabetes mellitus: prevention of amputation. J Am Podiatr Med Assoc. 1994;84:322-328.
  33. [31]. Zimny S, Schatz H, Pfohl M. The role of limited joint mobility in diabetic patients with an atrisk foot. Diabetes Care. 2004;27:942-946.
  34. [32]. Fernando DJ, Masson EA, Veves A, Boulton AJ. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care. 1991;14:811.
  35. [33]. Mueller MJ, Hastings M, Commean PK. et al. Forefoot structural predictors of plantar pressures during walking in people with diabetes and peripheral neuropathy. J Biomech. 2003;36:1009-1017.
  36. [34]. Veves A, Murray HJ, Young MJ, Boulton AJ. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia. 1992;35:660-663.
  37. [35]. American Diabetes Association. Consensus Development Conference on Diabetic Foot Wound Care. Diabetes Care. 1999;22:13-54.
  38. [36]. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrixmetalloproteinases and their inhibitors in the wounds of diabetic and nondiabetic patients. Diabetologia. 2002;45:1011-1016.
  39. [37]. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259-265.
  40. [38]. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341:1906-1912.
  41. [39]. Mayser P, Hensel J, Thoma W. et al. Prevalence of fungal foot infections in patients with diabetes mellitus type 1: underestimation of moccasintype tinea. Exp Clin Endocrinol Diabetes. 2004;112:264-268.
  42. [40]. Anarella JJ, Toth C, DeBello JA. Preventing complications in the diabetic patient with toenail onychomycosis. J Am Podiatr Med Assoc. 2001;91:325-328.
  43. [41]. Gupta AK, Humke S. The prevalence and management of onychomycosis in diabetic patients. Eur J Dermatol. 2000;10:379-384.
  44. [42]. Chincholikar DA, Pal RB. Study of fungal and bacterial infections of the diabetic foot. Indian J Pathol Microbiol. 2002;45:15-22.
  45. [43]. Ragnarson Tennvall G, Apelqvist J. Healthrelated quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications. 2000;14:235-241.
  46. [44]. Brod M. Quality of life issues in patients with diabetes and lower extremity ulcers: patients and care givers. Qual Life Res. 1998;7:365-372.
  47. [45]. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer: the Seattle Diabetic Foot Study. Diabetes Care. 1999;22:1036-1042.
  48. [46]. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med. 1998;158:157-162.